HKSE:06990 (China)
Â
Class H Shares
HK$
168.00
(+9.16%)
Apr 26
Business Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
ISIN : CNE1000062J1
Share Class Description:
HKSE:06990: Class H SharesCompare
Compare
Traded in other countries / regions
06990.Hong Kong IPO Date
2023-07-11Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 42.2 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 15.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 86.2 | |||||
| 9-Day RSI | 73.5 | |||||
| 14-Day RSI | 67.53 | |||||
| 6-1 Month Momentum % | 117.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.53 | |||||
| Quick Ratio | 2.47 | |||||
| Cash Ratio | 2.28 | |||||
| Days Inventory | 156.66 | |||||
| Days Sales Outstanding | 0.17 | |||||
| Days Payable | 610.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 8.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.64 | |||||
| Operating Margin % | -51.43 | |||||
| Net Margin % | -75.18 | |||||
| FCF Margin % | -31.7 | |||||
| ROA % | -14.93 | |||||
| ROIC % | -8.34 | |||||
| ROC (Joel Greenblatt) % | -39.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 70.68 | |||||
| PB Ratio | 14.45 | |||||
| Price-to-Tangible-Book | 14.7 | |||||
| EV-to-EBIT | -124.96 | |||||
| EV-to-Forward-EBIT | -46.62 | |||||
| EV-to-EBITDA | -135.21 | |||||
| EV-to-Revenue | 66.59 | |||||
| EV-to-Forward-Revenue | 34.38 | |||||
| EV-to-FCF | -210.07 | |||||
| Price-to-Net-Current-Asset-Value | 20.69 | |||||
| Price-to-Net-Cash | 24.96 | |||||
| Earnings Yield (Greenblatt) % | -0.8 | |||||
| FCF Yield % | -0.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 512.933 | ||
| EPS (TTM) (HK$) | -1.593 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 67.53 | ||
| 14-Day ATR (HK$) | 12.014309 | ||
| 20-Day SMA (HK$) | 145.9 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 60.6 - 175 | ||
| Shares Outstanding (Mil) | 219.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Frequently Asked Questions
What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)'s stock price today?
The current price of HKSE:06990 is HK$168.00. The 52 week high of HKSE:06990 is HK$175.00 and 52 week low is HK$60.60.
When is next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)?
The next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) is .
Does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) pay dividends? If so, how much?
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers